264 related articles for article (PubMed ID: 32689888)
1. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
[TBL] [Abstract][Full Text] [Related]
3. Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer.
Zenga J; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
Laryngoscope; 2020 Mar; 130(3):666-671. PubMed ID: 31206708
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
5. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold.
Bu DD; Ferrandino R; Robinson EM; Liu S; Miles BA; Teng MS; Yao M; Genden EM; Chai RL
Laryngoscope; 2021 Jan; 131(1):E184-E189. PubMed ID: 32348558
[TBL] [Abstract][Full Text] [Related]
7. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era.
Gal TJ; O'Brien KJ; Chen Q; Huang B
Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
9. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
[TBL] [Abstract][Full Text] [Related]
13. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
16. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
17. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
[TBL] [Abstract][Full Text] [Related]
18. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
[TBL] [Abstract][Full Text] [Related]
20. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
